Oak Thistle LLC Sells 507 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Oak Thistle LLC decreased its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 3.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 14,574 shares of the company’s stock after selling 507 shares during the period. Oak Thistle LLC’s holdings in Acadia Healthcare were worth $578,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Wellington Management Group LLP boosted its stake in shares of Acadia Healthcare by 12.2% in the third quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company’s stock valued at $739,250,000 after buying an additional 1,266,384 shares during the period. JPMorgan Chase & Co. raised its holdings in Acadia Healthcare by 17.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock valued at $198,258,000 after acquiring an additional 454,044 shares in the last quarter. State Street Corp grew its holdings in shares of Acadia Healthcare by 3.5% during the 3rd quarter. State Street Corp now owns 2,819,911 shares of the company’s stock worth $178,811,000 after purchasing an additional 95,613 shares in the last quarter. Point72 Asset Management L.P. increased its position in shares of Acadia Healthcare by 0.5% in the third quarter. Point72 Asset Management L.P. now owns 2,282,810 shares of the company’s stock worth $144,753,000 after purchasing an additional 12,470 shares during the period. Finally, Geode Capital Management LLC raised its stake in Acadia Healthcare by 0.9% in the third quarter. Geode Capital Management LLC now owns 1,613,198 shares of the company’s stock valued at $102,320,000 after purchasing an additional 14,197 shares in the last quarter.

Acadia Healthcare Price Performance

ACHC stock opened at $41.95 on Friday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. Acadia Healthcare Company, Inc. has a 52-week low of $36.50 and a 52-week high of $87.77. The company has a market capitalization of $3.90 billion, a P/E ratio of 13.75, a PEG ratio of 1.81 and a beta of 1.29. The company has a fifty day moving average price of $40.65 and a 200-day moving average price of $57.47.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The firm had revenue of $815.60 million for the quarter, compared to analyst estimates of $819.42 million. During the same quarter in the previous year, the company posted $0.91 EPS. The business’s revenue was up 8.7% on a year-over-year basis. As a group, equities analysts expect that Acadia Healthcare Company, Inc. will post 3.39 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on ACHC shares. Royal Bank of Canada reissued an “outperform” rating and issued a $64.00 target price on shares of Acadia Healthcare in a report on Friday, January 10th. Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and boosted their price objective for the company from $45.00 to $75.00 in a research report on Thursday, December 12th. Barclays lowered their price target on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a report on Friday, November 22nd. TD Cowen lowered their target price on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a research note on Tuesday, January 7th. Finally, StockNews.com cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, January 6th. One research analyst has rated the stock with a sell rating, two have given a hold rating and seven have given a buy rating to the company’s stock. According to MarketBeat.com, Acadia Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $70.22.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.